These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 3491151

  • 41. T cells and monocytes regulate the generation and functional activity of natural killer-derived lymphokine-activated killer cells.
    Atzpodien J, Gulati SC.
    Stem Cells; 1993 Nov; 11(6):511-8. PubMed ID: 8111310
    [Abstract] [Full Text] [Related]

  • 42. Limiting dilution analysis (LDA) of cells responding to recombinant interleukin-2 without previous stimulation: evidence that all responding cells are lymphokine-activated potent effectors.
    Vie H, Bonneville M, Sondermeyer P, Moreau JF, Soulillou JP.
    Immunology; 1986 Mar; 57(3):351-7. PubMed ID: 3082744
    [Abstract] [Full Text] [Related]

  • 43. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor).
    Gately MK, Desai BB, Wolitzky AG, Quinn PM, Dwyer CM, Podlaski FJ, Familletti PC, Sinigaglia F, Chizonnite R, Gubler U.
    J Immunol; 1991 Aug 01; 147(3):874-82. PubMed ID: 1713608
    [Abstract] [Full Text] [Related]

  • 44. Regulation of human natural killer cell migration and proliferation by the exodus subfamily of CC chemokines.
    Robertson MJ, Williams BT, Christopherson K, Brahmi Z, Hromas R.
    Cell Immunol; 2000 Jan 10; 199(1):8-14. PubMed ID: 10675270
    [Abstract] [Full Text] [Related]

  • 45. Triggering of thymocyte function by IL-2 as the only exogenous stimulus; analysis of two distinct modes of IL-2-induced thymocyte proliferation and IL-3 secretion in vitro.
    Bellio M, Dos Reis GA.
    Immunology; 1989 Oct 10; 68(2):175-80. PubMed ID: 2807375
    [Abstract] [Full Text] [Related]

  • 46. Interleukin 2 induces human acute lymphocytic leukemia cells to manifest lymphokine-activated-killer (LAK) cytotoxicity.
    Kaufmann Y, Levanon M, Davidsohn J, Ramot B.
    J Immunol; 1987 Aug 01; 139(3):977-82. PubMed ID: 3496395
    [Abstract] [Full Text] [Related]

  • 47. Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12.
    Warren HS, Kinnear BF, Phillips JH, Lanier LL.
    J Immunol; 1995 May 15; 154(10):5144-52. PubMed ID: 7730620
    [Abstract] [Full Text] [Related]

  • 48. Transient decrease in IL-2-responsive lymphocytes 24 hours after initiation of continuous IL-2 infusion in cancer patients.
    Weil-Hillman G, Hank JA, Rosenthal NS, Sondel PM.
    J Biol Response Mod; 1988 Oct 15; 7(5):424-37. PubMed ID: 3053997
    [Abstract] [Full Text] [Related]

  • 49. IL-2 receptors on circulating natural killer cells and T lymphocytes. Similarity in number and affinity but difference in transmission of the proliferation signal.
    Ben Aribia MH, Moiré N, Métivier D, Vaquero C, Lantz O, Olive D, Charpentier B, Senik A.
    J Immunol; 1989 Jan 15; 142(2):490-9. PubMed ID: 2783438
    [Abstract] [Full Text] [Related]

  • 50. The tumor promoter teleocidin induces IL 2 receptor expression and IL 2-independent proliferation of human peripheral blood T cells.
    Isakov N, Bleackley RC, Shaw J, Altman A.
    J Immunol; 1985 Oct 15; 135(4):2343-50. PubMed ID: 3928744
    [Abstract] [Full Text] [Related]

  • 51. Lysis of human T cell leukemia virus infected T and B lymphoid cells by interleukin 2-activated killer cells.
    Froelich CJ, Guiffaut S.
    J Immunol; 1987 Dec 01; 139(11):3637-43. PubMed ID: 2824611
    [Abstract] [Full Text] [Related]

  • 52. Differential effects of interleukin 2 vs B cell growth factor on human B cells.
    Nakagawa T, Nakagawa N, Ambrus JL, Fauci AS.
    J Immunol; 1988 Jan 15; 140(2):465-9. PubMed ID: 2447179
    [Abstract] [Full Text] [Related]

  • 53. Recombinant interleukin 2-activated natural killer cells regulate IgG2a production.
    Amigorena S, Bonnerot C, Fridman WH, Teillaud JL.
    Eur J Immunol; 1990 Aug 15; 20(8):1781-7. PubMed ID: 1698633
    [Abstract] [Full Text] [Related]

  • 54. Design and validation of a clinically applicable culture procedure for the generation of interleukin-2 activated natural killer cells in human bone marrow autografts.
    Klingemann HG, Deal H, Reid D, Eaves CJ.
    Exp Hematol; 1993 Aug 15; 21(9):1263-70. PubMed ID: 8330650
    [Abstract] [Full Text] [Related]

  • 55. Biological functions of recombinant human interleukin-2.
    Liu XY, Yu JL, Zheng HD, Chen Y, Shen JF, Feng ZH, Chen ZC, You LF, Sun BH, Zhou YY.
    Chin J Biotechnol; 1991 Aug 15; 7(1):25-31. PubMed ID: 1773013
    [Abstract] [Full Text] [Related]

  • 56. Rapid Il-2-induced adherence of human natural killer cells. Expression of mRNA for cytokines and IL-2 receptors in adherent NK cells.
    Vitolo D, Vujanovic NL, Rabinowich H, Schlesinger M, Herberman RB, Whiteside TL.
    J Immunol; 1993 Aug 15; 151(4):1926-37. PubMed ID: 8345189
    [Abstract] [Full Text] [Related]

  • 57. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. II. Regulatory role of interferon on proliferative and cytotoxic precursors.
    Vose BM, Riccardi C, Bonnard GD, Herberman RB.
    J Immunol; 1983 Feb 15; 130(2):768-72. PubMed ID: 6184405
    [Abstract] [Full Text] [Related]

  • 58. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F, Hashimoto W, Okamura H, Robbins PD, Lotze MT, Tahara H.
    Cancer Res; 2000 Sep 01; 60(17):4838-44. PubMed ID: 10987295
    [Abstract] [Full Text] [Related]

  • 59. Expression of prolactin receptor and response to prolactin stimulation of human NK cell lines.
    Sun R, Li AL, Wei HM, Tian ZG.
    Cell Res; 2004 Feb 01; 14(1):67-73. PubMed ID: 15040892
    [Abstract] [Full Text] [Related]

  • 60. Activation through CD3 molecule leads to clonal expansion of all human peripheral blood T lymphocytes: functional analysis of clonally expanded cells.
    Weber WE, Buurman WA, Vandermeeren MM, Raus JC.
    J Immunol; 1985 Oct 01; 135(4):2337-42. PubMed ID: 3875651
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.